BC Innovations | Jul 9, 2015
Distillery Therapeutics

Therapeutics: DNA polymerase III β subunit (DnaN)

Infectious disease INDICATION: Tuberculosis In vitro and mouse studies suggest the griselimycin analog cyclohexylgriselimycin (CGM) could help treat tuberculosis. Chemical synthesis and in vitro testing of analogs of Streptomyces-derived griselimycin identified CGM as a DnaN...
Items per page:
1 - 1 of 1